231 results on '"Mahnkopf Christian"'
Search Results
2. Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trial
3. Comparison of MRI and transthoracic echocardiography for detection of myocardial lesions in patients with coronary artery disease and preserved left ventricular function
4. DE-MRI allows comparison of lesion formation after pulmonary vein isolation with different ablation catheters in patients with paroxysmal atrial fibrillation
5. Variant pulmonary vein anatomy detected by cardiac MRI may predict outcome after pulmonary vein isolation in patients with atrial fibrillation
6. Observation of renal function after multiple DE-MRI examinations in atrial fibrillation ablation patients without kidney diseases
7. Magnetic resonance imaging for optimized implantation and long-term monitoring of patients receiving a left atrial appendage occluder
8. Cardiac MRI allows evaluation of different ablation techniques in patients undergoing pulmonary vein ablation
9. Pulmonary vein stenoses are reversible early after plumonary vein isolation in patients with paroxysmal atrial fibrillation – a cardiac mri analysis
10. Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trial
11. Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design
12. Kardiale Magnetresonanztomographie und Myokard: Differenzierung zwischen vitalem und avitalem Gewebe
13. Abstract 12367: Sex-Specific Differences in Quality of Life and Atrial Fibrillation Recurrence Following Ablation of Persistent Atrial Fibrillation: Insights From the DECAAF II Trial
14. Abstract 12357: Investigating Sex-Specific Factors Influencing Atrial Fibrillation Burden in Patients With Persistent Atrial Fibrillation: A DECAAF II Subanalysis
15. Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial
16. Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial
17. Abstract 14109: Safety and Effectiveness of Trans-Catheter Tricuspid Valve Repair in the Elderly and Very Elderly Patients
18. Predictive Factors and Safety of Noninvasive Mechanical Ventilation in Combination With Propofol Deep Sedation in Left Atrial Ablation Procedures
19. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial
20. Feasibility and Efficacy of Transcatheter Tricuspid Valve Repair in Patients with Cardiac Implanted Electrical Devices and Trans-Tricuspid Leads
21. Abstract 16648: Covid-19 at the ICU: A Multiorgan Challenge
22. Abstract 14899: Personalized Computational Modeling Identifies Embolic Stroke of Undetermined Source Patients With Potential Arrhythmic Substrate
23. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY
24. Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
25. Successful Thrombolysis of Acute Upper Limb Ischemia Using Ekosonic Endovascular System Ultrasound Catheter in a Patient With Atrial Fibrillation
26. Abstract 18093: Unleashing the Role of Speckle Tracking Echocardiography in Detection of Left Atrial Fibrosis
27. Gender-specific differences in patients who underwent left atrial appendage closure
28. PO-04-143 A PRAGMATIC SCORE FOR BASELINE ATRIAL FIBROSIS PREVALENCE IN PERSISTENT ATRIAL FIBRILLATION PATIENTS UNDERGOING ABLATION
29. PO-04-142 BASELINE NATRIURETIC PEPTIDES IS A STRONG MARKER OF ATRIAL REMODELING IN NON-HEART FAILURE PATIENTS WITH PERSISTENT AF UNDERGOING PULMONARY VEIN ISOLATION
30. PO-03-090 IMPACT OF ABLATION ENERGY AND SUBSTRATE MODIFICATION ON REGRESSION FROM PERSISTENT ATRIAL FIBRILLATION TO PAROXYSMAL ATRIAL FIBRILLATION
31. PO-03-132 DIRECT CATHETER ABLATION VERSUS CATHETER ABLATION POST ANTIARRHYTHMIC DRUG THERAPY FOR PERSISTENT ATRIAL FIBRILLATION: EFFECT ON ARRHYTHMIA RECURRENCE, AF BURDEN, EARLY LEFT ATRIUM REMODELING AND QUALITY OF LIFE
32. PO-03-131 AGE-RELATED LEFT ATRIAL REMODELING AND EFFICACY OF CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION
33. PO-03-129 LESSONS LEARNED FROM VARIATION IN RADIOFREQUENCY ENERGY DELIVERY SETTINGS IN A MULTICENTER RANDOMIZED TRIAL: IMPORTANCE OF POWER AND DURATION
34. AB-482902-004 FEMALE SEX IS THE STRONGEST PREDICTOR OF AF RECURRENCE AFTER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: INSIGHTS FROM DECAAF II
35. BASELINE NATRIURETIC PEPTIDES AND LEFT ATRIAL VOLUME ARE THE STRONGEST PREDICTORS OF AF BURDEN IN NON-HEART FAILURE PATIENTS WITH PERSISTENT AF UNDERGOING PULMONARY VEIN ISOLATION
36. MACHINE LEARNING-BASED CLUSTER ANALYSIS IDENTIFIES PATIENT PHENOTYPES FOR RISK OF ATRIAL ARRHYTHMIA RECURRENCE FOLLOWING CATHETER ABLATION IN PAROXYSMAL ATRIAL FIBRILLATION
37. Optimal Ablation Settings Predicting Durable Scar Detected Using LGE-MRI after Modified Left Atrial Anterior Line Ablation
38. How to remove an embolized TriClip from the femoral vein? Case report
39. Abstract 13227: Safety and Effectiveness of Trans-Catheter Mitral Valve Repair in the Elderly and Very Elderly Patients
40. MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF Study
41. Lesion formation after pulmonary vein isolation using the advance cryoballoon and the standard cryoballoon: lessons learned from late gadolinium enhancement magnetic resonance imaging
42. Improvement in Estimated Glomerular Filtration Rate in Patients with Chronic Kidney Disease Undergoing Catheter Ablation for Atrial Fibrillation
43. Dreidimensionale Mappingsysteme
44. Atrial fibrosis in embolic stroke of undetermined source: A multicenter study
45. Atrial fibrosis progression in patients with no history of atrial fibrillation
46. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF Study
47. Computational modeling identifies embolic stroke of undetermined source patients with potential arrhythmic substrate
48. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.
49. Author response: Computational modeling identifies embolic stroke of undetermined source patients with potential arrhythmic substrate
50. Effects of Environmental Factors on Severity and Mortality of COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.